Table of Contents
Can AI Tools Like AlphaFold and Grok Really Treat Canine Cancer?
The True AI Workflow
Media outlets recently highlighted Paul Conyngham for developing a custom mRNA cancer vaccine for his dog, Rose. Many headlines incorrectly attributed the entire technical achievement to ChatGPT. Conyngham actually deployed three distinct AI platforms to handle specific phases of this complex medical challenge. He first paid $3,000 to sequence Rose’s tumor DNA after veterinarians issued a terminal prognosis. He then used ChatGPT strictly to research options and map out the initial treatment strategy.
Protein Modeling and Design
Conyngham operates as a technology consultant without formal biology training. This lack of medical background required him to rely on highly specialized tools for the molecular engineering phases. He fed the genetic data into Google DeepMind’s AlphaFold to accurately model the mutated proteins. He subsequently transferred the project to Grok to design the actual mRNA sequence. Grok successfully produced a codon-optimized sequence targeting the tumor mutations, complete with essential stability features like a 5′ cap, a poly-A tail, and UTRs.
Treatment Timeline and Results
The University of New South Wales synthesized the custom vaccine and initiated the treatment campaign in December 2025. Some earlier reports cited a June 2025 article stating the cancer was progressing, but the actual mRNA therapy did not begin until December. By January 2026, Rose demonstrated substantial physical improvements. Severe fluid retention in her leg subsided entirely, making her Achilles tendon visible once again. Conyngham reported that the tumors flattened, changed color, and decreased in volume by roughly 75 percent.
Medical Context and Accuracy
Evaluating experimental medical interventions requires strict attention to clinical variables. Veterinarians co-administered this custom mRNA vaccine alongside an established anticancer medication. This dual approach makes it scientifically difficult to measure the independent efficacy of the AI-designed construct. Accurate reporting remains vital when discussing experimental biomedical research. Acknowledging the precise roles of ChatGPT, AlphaFold, and Grok provides researchers with a realistic understanding of how artificial intelligence currently functions in clinical oncology.